Diabetes induces gender gap on LCAT levels and activity

Life Sciences

Volumn 92, Issue 1, 2013, Pages 51-54

  Nakhjavani, Manouchehr ^a   Morteza, Afsaneh ^a   Karimi, Reza ^a   Banihashmi, Zahra ^a   Esteghamati, Alireza ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Lecitin cholesterol acyltransferase (LCAT); Sex characteristics; Type 2 diabetes mellitus

Indexed keywords

CREATININE; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PHOSPHATIDYLCHOLINE STEROL ACYLTRANSFERASE; STATIN (PROTEIN); TRIACYLGLYCEROL;

ADULT; ARTICLE; BLOOD SAMPLING; BODY MASS; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CROSS-SECTIONAL STUDY; DIASTOLIC BLOOD PRESSURE; ENZYME ACTIVITY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HUMAN TISSUE; INSULIN RESISTANCE; INSULIN TREATMENT; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; SEX DIFFERENCE; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL;

BLOOD GLUCOSE; BLOOD PRESSURE; BODY MASS INDEX; CASE-CONTROL STUDIES; CHOLESTEROL, HDL; CHOLESTEROL, LDL; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; LINEAR MODELS; MALE; MIDDLE AGED; PHOSPHATIDYLCHOLINE-STEROL O-ACYLTRANSFERASE; SEX FACTORS; TRIGLYCERIDES;

EID: 84871925841     PISSN: 00243205     EISSN: 18790631     Source Type: Journal    
DOI: 10.1016/j.lfs.2012.10.026     Document Type: Article

References (41)

1. J.J. Albers, C. Chen, and J.L. Adolphson Familial lecithin-cholesterol acyltransferase: identification of heterozygotes with half-normal enzyme activity and mass Hum Genet 58 1981 306 309
2. J.J. Albers, C.H. Chen, and J.L. Adolphson Lecithin:cholesterol acyltransferase (LCAT) mass; its relationship to LCAT activity and cholesterol esterification rate J Lipid Res 22 1981 1206 1213
3. J.J. Albers, R.O. Bergelin, J.L. Adolphson, and P.W. Wahl Population-based reference values for lecithin-cholesterol acyltransferase (LCAT) Atherosclerosis 43 1982 369 379
4. American Diabetes Association Diabetes Care 33 Suppl. 1 2010 S62 S69 http://dx.doi.org/10.2337/dc10-S062
5. L. Bajnok, I. Seres, Z. Varga, S. Jeges, A. Peti, and Z. Karanyi Relationship of endogenous hyperleptinemia to serum paraoxonase 1, cholesteryl ester transfer protein, and lecithin cholesterol acyltransferase in obese individuals Metabolism 56 2007 1542 1549
6. J. Chung, D. Abano, R. Byrne, and A.M. Scanu In vitro mass: activity distribution of lecithin-cholesterol acyltransferase among human plasma lipoproteins Atherosclerosis 45 1982 33 41
7. L. Dory, C.H. Sloop, L.M. Boquet, R.L. Hamilton, and P.S. Roheim Lecithin:cholesterol acyltransferase-mediated modification of discoidal peripheral lymph high density lipoproteins: possible mechanism of formation of cholesterol-induced high density lipoproteins (HDLc) in cholesterol-fed dogs Proc Natl Acad Sci U S A 80 1983 3489 3493
8. R.P. Dullaart, B.J. Beusekamp, S.C. Riemens, K. Hoogenberg, B.K. Stulp, and A. Van Tol High-density lipoprotein cholesterol is related to the TaqIB cholesteryl ester transfer protein gene polymorphism and smoking, but not to moderate alcohol consumption in insulin-dependent diabetic men Scand J Clin Lab Invest 58 1998 251 258
9. R.P. Dullaart, F. Perton, W.J. Sluiter, R. De Vries, and A. Van Tol Plasma lecithin: cholesterol acyltransferase activity is elevated in metabolic syndrome and is an independent marker of increased carotid artery intima media thickness J Clin Endocrinol Metab 93 2008 4860 4866
10. R.P. Dullaart, F. Perton, P.J. Kappelle, R. De Vries, W.J. Sluiter, and A. Van Tol Plasma lecithin: cholesterol acyltransferase activity modifies the inverse relationship of C-reactive protein with HDL cholesterol in nondiabetic men Biochim Biophys Acta 1801 2010 84 88
11. R.P. Dullaart, A. Constantinides, F.G. Perton, J.J. Van Leeuwen, J.L. Van Pelt, and R. De Vries Plasma cholesteryl ester transfer, but not cholesterol esterification, is related to lipoprotein-associated phospholipase A2: possible contribution to an atherogenic lipoprotein profile J Clin Endocrinol Metab 96 2011 1077 1084
12. S.M. Grundy, B. Howard, S. Smith JR., R. Eckel, R. Redberg, and R.O. Bonow Prevention Conference VI: Diabetes and Cardiovascular Disease: executive summary: conference proceeding for healthcare professionals from a special writing group of the American Heart Association Circulation 105 2002 2231 2239
13. M.I. Harris, W.C. Hadden, W.C. Knowler, and P.H. Bennett Prevalence of diabetes and impaired glucose tolerance and plasma glucose levels in U.S. population aged 20-74 yr Diabetes 36 1987 523 534
14. J.M. Hoeg, S. Santamarina-Fojo, A.M. Berard, J.F. Cornhill, E.E. Herderick, and S.H. Feldman Overexpression of lecithin: cholesterol acyltransferase in transgenic rabbits prevents diet-induced atherosclerosis Proc Natl Acad Sci U S A 93 1996 11448 11453
15. F.B. Hu, M.J. Stampfer, C.G. Solomon, S. Liu, W.C. Willett, and F.E. Speizer The impact of diabetes mellitus on mortality from all causes and coronary heart disease in women: 20 years of follow-up Arch Intern Med 161 2001 1717 1723
16. A. Juutilainen, S. Kortelainen, S. Lehto, T. Ronnemaa, K. Pyorala, and M. Laakso Gender difference in the impact of type 2 diabetes on coronary heart disease risk Diabetes Care 27 2004 2898 2904
17. A.M. Kanaya, D. Grady, and E. Barrett-Connor Explaining the sex difference in coronary heart disease mortality among patients with type 2 diabetes mellitus: a meta-analysis Arch Intern Med 162 2002 1737 1745
18. P.J. Kappelle, J.F. De Boer, F.G. Perton, W. Annema, R. De Vries, and R.P. Dullaart Increased LCAT activity and hyperglycaemia decrease the antioxidative functionality of HDL Eur J Clin Invest 42 2012 487 495
19. K. Kempf, B. Rose, C. Herder, U. Kleophas, S. Martin, and H. Kolb Inflammation in metabolic syndrome and type 2 diabetes: impact of dietary glucose Ann N Y Acad Sci 1084 2006 30 48
20. E.P. Kilsdonk, A.N. Dorsman, and A. Van Tol Effect of LCAT on HDL-mediated cholesterol efflux from loaded EA.hy 926 cells Int J Biochem 25 1993 219 221
21. W.L. Lee, A.M. Cheung, D. Cape, and B. Zinman Impact of diabetes on coronary artery disease in women and men: a meta-analysis of prospective studies Diabetes Care 23 2000 962 968
22. R.G. Lee, K.L. Kelley, J.K. Sawyer, R.V. Farese JR., J.S. Parks, and L.L. Rudel Plasma cholesteryl esters provided by lecithin:cholesterol acyltransferase and acyl-coenzyme a:cholesterol acyltransferase 2 have opposite atherosclerotic potential Circ Res 95 2004 998 1004
23. D.R. Matthews, J.P. Hosker, A.S. Rudenski, B.A. Naylor, D.F. Treacher, and R.C. Turner Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man Diabetologia 28 1985 412 419
24. F.C. Mcgillicuddy, M. De La Llera Moya, C.C. Hinkle, M.R. Joshi, E.H. Chiquoine, and J.T. Billheimer Inflammation impairs reverse cholesterol transport in vivo Circulation 119 2009 1135 1145
25. K. Mekki, M. Bouchenak, M. Remaoun, and J.L. Belleville Effect of long-term hemodialysis on plasma lecithin: cholesterol acyltransferase activity and the amounts and compositions of HDL2 and HDL3 in hemodialysis-treated patients with chronic renal failure: a 9-year longitudinal study Med Sci Monit 10 2004 CR439 CR446
26. H. Moradi, M.V. Pahl, R. Elahimehr, and N.D. Vaziri Impaired antioxidant activity of high-density lipoprotein in chronic kidney disease Transl Res 153 2009 77 85
27. M. Nakhjavani, A. Esteghamati, F. Esfahanian, A. Ghanei, A. Rashidi, and S. Hashemi HbA1c negatively correlates with LCAT activity in type 2 diabetes Diabetes Res Clin Pract 81 2008 38 41
28. M. Nakhjavani, F. Asgharani, O. Khalilzadeh, A. Esteghamati, A. Ghaneei, and A. Morteza Oxidized low-density lipoprotein is negatively correlated with lecithin-cholesterol acyltransferase activity in type 2 diabetes mellitus Am J Med Sci 341 2011 92 95
29. J.R. Nofer Hyperlipidaemia and cardiovascular disease: HDL, inflammation and surprising results of AIM-HIGH study Curr Opin Lipidol 23 2012 260 262
30. F. Peelman, J. Vandekerckhove, and M. Rosseneu Structure and function of lecithin cholesterol acyl transferase: new insights from structural predictions and animal models Curr Opin Lipidol 11 2000 155 160
31. A. Sandoo, J.J. Veldhuijzen Van Zanten, T.E. Toms, D. Carroll, and G.D. Kitas Anti-TNFalpha therapy transiently improves high density lipoprotein cholesterol levels and microvascular endothelial function in patients with rheumatoid arthritis: a Pilot Study BMC Musculoskelet Disord 13 2012 127
32. A.M. Scanu, and C. Edelstein HDL: bridging past and present with a look at the future FASEB J 22 2008 4044 4054
33. F. Scarpini, R. Cappellone, A. Auteri, and L. Puccetti Role of genetic factors in statins side-effects Cardiovasc Hematol Disord Drug Targets 2011 PubMed ID: 22524173
34. N. Solajic-Bozicevic, A. Stavljenic, and M. Sesto Lecithin:cholesterol acyltransferase activity in patients with acute myocardial infarction and coronary heart disease Artery 18 1991 326 340
35. S.A. Sorrentino, C. Besler, L. Rohrer, M. Meyer, K. Heinrich, and F.H. Bahlmann Endothelial-vasoprotective effects of high-density lipoprotein are impaired in patients with type 2 diabetes mellitus but are improved after extended-release niacin therapy Circulation 121 2010 110 122
36. R.C. Turner, H. Millns, H.A. Neil, I.M. Stratton, S.E. Manley, and D.R. Matthews Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS: 23) BMJ 316 1998 823 828
37. G. Utermann, H.J. Menzel, K.H. Langer, and P. Dieker Lipoproteins in lecithin-cholesterol-acyltransferase(LCAT)-deficiency. II. Further studies on the abnormal high-density-lipoproteins Humangenetik 27 1975 185 187
38. G. Utermann, H.J. Menzel, G. Adler, P. Dieker, and W. Weber Substitution in vitro of lecithin-cholesterol acyltransferase. Analysis of changes in plasma lipoproteins Eur J Biochem 107 1980 225 241
39. S. Van Linthout, F. Spillmann, H.P. Schultheiss, and C. Tschope High-density lipoprotein at the interface of type 2 diabetes mellitus and cardiovascular disorders Curr Pharm Des 16 2010 1504 1516
40. N.D. Vaziri Lipotoxicity and impaired high density lipoprotein-mediated reverse cholesterol transport in chronic kidney disease J Ren Nutr 20 2010 S35 S43
41. P.T. Williams, J.J. Albers, R.M. Krauss, and P.D. Wood Associations of lecithin: cholesterol acyltransferase (LCAT) mass concentrations with exercise, weight loss, and plasma lipoprotein subfraction concentrations in men Atherosclerosis 82 1990 53 58